State Street SPDR S&P Pharmaceuticals ETF
XPH
XPH
64 hedge funds and large institutions have $117M invested in State Street SPDR S&P Pharmaceuticals ETF in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 16 increasing their positions, 25 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less call options, than puts
Call options by funds: $ | Put options by funds: $
36% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 25
44% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 9
Holders
64
Holding in Top 10
–
Calls
$783K
Puts
$1.12M
Top Buyers
| 1 | +$1.92M | |
| 2 | +$1.91M | |
| 3 | +$1.13M | |
| 4 |
SW
SVB Wealth
Boston,
Massachusetts
|
+$325K |
| 5 |
EWA
EP Wealth Advisors
Torrance,
California
|
+$275K |
Top Sellers
| 1 | -$1.58M | |
| 2 | -$1.49M | |
| 3 | -$950K | |
| 4 |
CI
CX Institutional
Auburn,
Indiana
|
-$739K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$730K |